1 | 2 | 3 | 4 | 5 | 6 | Washout | 7 | 8 | 9 | 10 | 11 | 12 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Week | Screening | Baseline | 1 | 2 | 3 | 4 | (4 weeks) | 8 | 9 | 10 | 11 | 12 | 16 |
In/exclusion criteria checking | × | ||||||||||||
Enrolment | × | ||||||||||||
Obtaining informed consent | × | ||||||||||||
Physical examination | × | ||||||||||||
Randomization | × | × | |||||||||||
Blood pressure | × | × | × | × | × | × | × | × | × | × | × | × | |
LFT | × | × | × | × | × | ||||||||
RFT | × | × | × | × | × | ||||||||
Lipid profile measurement | × | × | × | × | |||||||||
Blood markers measurement | × | × | × | × | |||||||||
Hematological indices and FBG measurement | × | × | × | × | × | ||||||||
Compliance measurement | × | × | × | × | × | × | × | × | × | ||||
Adverse effect checking | × | × | × | × | × | × | × | × | × |